Our findings reveal that 5'-tiRNA-Lys modulates autophagy through EWSR1-mediated miR-125a processing, which in turn affects intestinal inflammation, highlighting the potential of 5'-tiRNA-Lys as a therapeutic target for IBD. This evidence concerns the gene EWSR1 and inflammatory bowel disease.